Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Neoplasm Malignant Resectable”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Not applicableActive Not RecruitingNCT07184047
What this trial is testing

Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers

Who this might be right for
Gastrointestinal CancersFrailtySarcopenia in Elderly+8 more
Ankara Etlik City Hospital 72
Testing effectiveness (Phase 2)Study completedNCT04224402
What this trial is testing

Efficacy and Safety of mFOLFIRINOX as Postoperative Chemotherapy for Pancreatic Cancer in Chinese Patients.

Who this might be right for
Pancreatic Cancer Resectable
Yuhong Li 80
Large-scale testing (Phase 3)Ended earlyNCT01836432
What this trial is testing

Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Carcinoma Non-resectableLocally Advanced Malignant Neoplasm
NewLink Genetics Corporation 302
Not applicableLooking for participantsNCT06375967
What this trial is testing

EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)

Who this might be right for
Malignant Biliary ObstructionBiliary Tract NeoplasmsPancreatic Cancer Non-resectable
Hospital Universitari de Bellvitge 128
Not applicableStudy completedNCT01321450
What this trial is testing

Economisation of Whipple Resection Using an Ultrasonic Dissection Device

Who this might be right for
Resectable Pancreatic Head NeoplasmResectable Periampullary NeoplasmChronic Pancreatitis
Universitätsklinikum Hamburg-Eppendorf 82
Very early researchUnknownNCT05287165
What this trial is testing

Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms

Who this might be right for
Advanced Solid TumorsDigestive System NeoplasmsPancreatic Cancer Resectable+1 more
Beijing Immunochina Medical Science & Technology Co., Ltd. 19
Not applicableNot Yet RecruitingNCT06495749
What this trial is testing

Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures

Who this might be right for
Pancreatic Cancer Resectable
Zhejiang University 3,000
Post-approval studies (Phase 4)Looking for participantsNCT06368063
What this trial is testing

The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Resectable
Xi'an Jiaotong University 642
Large-scale testing (Phase 3)UnknownNCT05181605
What this trial is testing

Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors

Who this might be right for
Pancreatic AdenocarcinomaPancreatic Cancer Resectable
Instituto de investigación e innovación biomédica de Cádiz 116
Not applicableLooking for participantsNCT06287749
What this trial is testing

French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

Who this might be right for
Pancreatic Cancer ResectablePancreatic Ductal AdenocarcinomaMinimal Residual Disease+2 more
University Hospital, Montpellier 37
Not applicableActive Not RecruitingNCT07326150
What this trial is testing

Construction of a Predictive Model for the Efficacy of Chemoprevention Combined With Targeted Therapy in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer ResectablePancreatic Cancer Non-resectable
Zhejiang Cancer Hospital 70
Testing effectiveness (Phase 2)Study completedNCT01118897
What this trial is testing

Tomotherapy in Locally Advanced Gallbladder and Pancreatic Cancers

Who this might be right for
Pancreatic Neoplasms MalignantMalignant Neoplasm of Gall Bladder Non-resectable
Tata Memorial Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT05083247
What this trial is testing

Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmPancreatic AdenocarcinomaBorderline Resectable Pancreatic Adenocarcinoma
Erasme University Hospital 256
Not applicableNot Yet RecruitingNCT06670547
What this trial is testing

Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography

Who this might be right for
CholedocholithiasisCholedocholithiasis With Acute CholangitisCholangiocarcinoma+4 more
Germans Trias i Pujol Hospital 3,000
Not applicableLooking for participantsNCT07157605
What this trial is testing

Oncological Safety of Spleen Preservation in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)

Who this might be right for
Pancreatic Cancer ResectablePancreatectomy
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 94
Not applicableNot Yet RecruitingNCT06703905
What this trial is testing

Conventional Partial Pancreatoduodenectomy Versus an Extended Pancreatoduodenectomy for Pancreatic Head Cancers

Who this might be right for
Pancreatic Cancer Resectable
First Affiliated Hospital Xi'an Jiaotong University 270
Not applicableNot Yet RecruitingNCT06375928
What this trial is testing

EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial)

Who this might be right for
Malignant Biliary ObstructionPancreatic Cancer ResectableBiliary Tract Neoplasms
Hospital Universitari de Bellvitge 44
Very early researchLooking for participantsNCT06496373
What this trial is testing

Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer

Who this might be right for
Pancreatic Cancer ResectableChemotherapy-intolerant
Ruijin Hospital 20
Not applicableStudy completedNCT06809374
What this trial is testing

Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Resectable
Kochi University 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06888674
What this trial is testing

Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer Resectable
Zhejiang University 60
Load More Results